# Risedronate in Osteopenic Postmenopausal Women

> **NCT00345644** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 156 (estimated)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** risedronate
- **DRUG:** risedronate placebo

## Key facts

- **NCT ID:** NCT00345644
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2009-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00345644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00345644, "Risedronate in Osteopenic Postmenopausal Women". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00345644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*